Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1987 Apr;55(4):955–962. doi: 10.1128/iai.55.4.955-962.1987

Test of the virulence and live-vaccine efficacy of auxotrophic and galE derivatives of Salmonella choleraesuis.

N A Nnalue, B A Stocker
PMCID: PMC260444  PMID: 3104209

Abstract

Aromatic compound-dependent (aro) derivatives of three mouse-virulent strains of Salmonella choleraesuis (Salmonella cholerae-suis) were constructed and shown to be nonvirulent for mice (intraperitoneal [i.p.] 50% lethal dose [LD50], greater than 5 X 10(6) CFU). A pur derivative, and a thy derivative, each of a different virulent parent, remained moderately virulent (i.p. LD50S for BALB/c mice, ca. 10(5) and 5 X 10(4) CFU, respectively). Tested as live vaccines i.p., the aro strains were ineffective in salmonella-susceptible BALB/c and C57BL/6 mice but were somewhat effective in salmonella-resistant CBA/J mice and in outbred CD-1 mice. The pur and thy strains were effective as live vaccines in BALB/c mice when given in sublethal doses. Two previously isolated nonvirulent galE derivatives of S. choleraesuis (i.p. LD50 in BALB/c mice, greater than 10(6) CFU) were also ineffective as live vaccines in BALB/c and C57BL/6 mice. The main antigenic difference between S. choleraesuis (O-6,7) and S. typhimurium (O-4,12) is in O-antigen character, thought to largely determine the specificity of protection in salmonellosis. Paired, nearly isogenic O-6,7 and O-4,12 derivatives were constructed from an aro S. typhimurium strain of proven efficacy as a live vaccine. Used as live vaccines, the O-4,12 member protected BALB/c mice against challenge with virulent S. typhimurium, whereas the O-6,7 member did not protect against virulent S. choleraesuis. However, BALB/c mice vaccinated with the O-6,7 member and mice vaccinated with an aro S. choleraesuis strain were protected against challenge with a moderately virulent (LD50, 5 X 10(4) CFU) O-6,7 derivative of an S. typhimurium strain.

Full text

PDF
955

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BACON G. A., BURROWS T. W., YATES M. The effects of biochemical mutation on the virulence of Bacterium typhosum: the virulence of mutants. Br J Exp Pathol. 1950 Dec;31(6):714–724. [PMC free article] [PubMed] [Google Scholar]
  2. Baskerville A., Dow C. Pathology of experimental pneumonia in pigs produced by Salmonella cholerae-suis. J Comp Pathol. 1973 Apr;83(2):207–215. doi: 10.1016/0021-9975(73)90044-3. [DOI] [PubMed] [Google Scholar]
  3. DAVIS B. D., MINGIOLI E. S. Mutants of Escherichia coli requiring methionine or vitamin B12. J Bacteriol. 1950 Jul;60(1):17–28. doi: 10.1128/jb.60.1.17-28.1950. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Enomoto M., Stocker B. A. Transduction by phage P1kc in Salmonella typhimurium. Virology. 1974 Aug;60(2):503–514. doi: 10.1016/0042-6822(74)90344-4. [DOI] [PubMed] [Google Scholar]
  5. Germanier R., Füer E. Isolation and characterization of Gal E mutant Ty 21a of Salmonella typhi: a candidate strain for a live, oral typhoid vaccine. J Infect Dis. 1975 May;131(5):553–558. doi: 10.1093/infdis/131.5.553. [DOI] [PubMed] [Google Scholar]
  6. Germanier R. Immunity in Experimental Salmonellosis I. Protection Induced by Rough Mutants of Salmonella typhimurium. Infect Immun. 1970 Sep;2(3):309–315. doi: 10.1128/iai.2.3.309-315.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gots J. S., Benson C. E., Jochimsen B., Koduri K. R. Microbial models and regulatory elements in the control of purine metabolism. Ciba Found Symp. 1977;(48):23–41. doi: 10.1002/9780470720301.ch3. [DOI] [PubMed] [Google Scholar]
  8. HASHIMOTO H., HONDA T., KAWAKAMI M., MITSUHASHI S. Studies on the experimental salmonellosis. VI. Longlasting immunity of mouse immunized with live vaccine of Salmonella enteritidis. Jpn J Exp Med. 1961 Jun;31:187–190. [PubMed] [Google Scholar]
  9. Hoiseth S. K., Stocker B. A. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature. 1981 May 21;291(5812):238–239. doi: 10.1038/291238a0. [DOI] [PubMed] [Google Scholar]
  10. Ivánovics G., Marjai E., Dobozy A. The growth of purine mutants of Bacillus anthracis in the body of the mouse. J Gen Microbiol. 1968 Sep;53(2):147–162. doi: 10.1099/00221287-53-2-147. [DOI] [PubMed] [Google Scholar]
  11. KONDO E., MITSUHASHI S. DRUG RESISTANCE OF ENTERIC BACTERIA. IV. ACTIVE TRANSDUCING BACTERIOPHAGE P1 CM PRODUCED BY THE COMBINATION OF R FACTOR WITH BACTERIOPHAGE P1. J Bacteriol. 1964 Nov;88:1266–1276. doi: 10.1128/jb.88.5.1266-1276.1964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Lyman M. B., Stocker B. A., Roantree R. J. Comparison of the virulence of O:9,12 and O:4,5,12 Salmonella typhimurium his+ transductants for mice. Infect Immun. 1977 Feb;15(2):491–499. doi: 10.1128/iai.15.2.491-499.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Lyman M. B., Stocker B. A., Roantree R. J. Evaluation of the immune response directed against the Salmonella antigenic factors O4,5 and O9. Infect Immun. 1979 Dec;26(3):956–965. doi: 10.1128/iai.26.3.956-965.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. MACCREADY R. A., REARDON J. P., SAPHRA I. Salmonellosis in Massachusetts; a sixteen-year experience. N Engl J Med. 1957 Jun 13;256(24):1121–1128. doi: 10.1056/NEJM195706132562401. [DOI] [PubMed] [Google Scholar]
  15. Mäkelä P. H. Participation of lipopolysaccharide genes in the determination of the entobacterial common antigen: analysis in Salmonella groups B and C1. J Bacteriol. 1974 Sep;119(3):765–770. doi: 10.1128/jb.119.3.765-770.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Ornellas E. P., Stocker B. A. Relation of lipopolysaccharide character to P1 sensitivity in Salmonella typhimurium. Virology. 1974 Aug;60(2):491–502. doi: 10.1016/0042-6822(74)90343-2. [DOI] [PubMed] [Google Scholar]
  17. Robertsson J. A., Lindberg A. A., Hoiseth S., Stocker B. A. Salmonella typhimurium infection in calves: protection and survival of virulent challenge bacteria after immunization with live or inactivated vaccines. Infect Immun. 1983 Aug;41(2):742–750. doi: 10.1128/iai.41.2.742-750.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Robson H. G., Vas S. I. Resistance of inbred mice to Salmonella typhimurium. J Infect Dis. 1972 Oct;126(4):378–386. doi: 10.1093/infdis/126.4.378. [DOI] [PubMed] [Google Scholar]
  19. Rosner J. L. Formation, induction, and curing of bacteriophage P1 lysogens. Virology. 1972 Jun;48(3):679–689. doi: 10.1016/0042-6822(72)90152-3. [DOI] [PubMed] [Google Scholar]
  20. SAPHRA I., WINTER J. W. Clinical manifestations of salmonellosis in man; an evaluation of 7779 human infections identified at the New York Salmonella Center. N Engl J Med. 1957 Jun 13;256(24):1128–1134. doi: 10.1056/NEJM195706132562402. [DOI] [PubMed] [Google Scholar]
  21. SMITH H. W. THE IMMUNIZATION OF MICE, CALVES AND PIGS AGAINST SALMONELLA DUBLIN AND SALMONELLA CHOLERAE-SUIS INFECTIONS. J Hyg (Lond) 1965 Mar;63:117–135. doi: 10.1017/s0022172400045022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Schmieger H. Phage P22-mutants with increased or decreased transduction abilities. Mol Gen Genet. 1972;119(1):75–88. doi: 10.1007/BF00270447. [DOI] [PubMed] [Google Scholar]
  23. Smith B. P., Reina-Guerra M., Hoiseth S. K., Stocker B. A., Habasha F., Johnson E., Merritt F. Aromatic-dependent Salmonella typhimurium as modified live vaccines for calves. Am J Vet Res. 1984 Jan;45(1):59–66. [PubMed] [Google Scholar]
  24. Smith H. W., Tucker J. F. The virulence of trimethoprim-resistant thymine-requiring strains of Salmonella. J Hyg (Lond) 1976 Feb;76(1):97–108. doi: 10.1017/s0022172400054991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. USHIBA D., SAITO K., AKIYAMA T., NAKANO M., SUGIYAMA T., SHIRONO S. Studies on experimental typhoid: bacterial multiplication and host cell response after infection with Salmonella enteritidis in mice immunized with live and killed vaccines. Jpn J Microbiol. 1959 Apr;3:231–242. doi: 10.1111/j.1348-0421.1959.tb00119.x. [DOI] [PubMed] [Google Scholar]
  26. Valtonen M. V., Larinkari U. M., Plosila M., Valtonen V. V., Mäkelä P. H. Effect of enterobacterial common antigen on mouse virulence of Salmonella typhimurium. Infect Immun. 1976 Jun;13(6):1601–1605. doi: 10.1128/iai.13.6.1601-1605.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Valtonen V. V. Mouse virulence of Salmonella strains: the effect of different smooth-type O side-chains. J Gen Microbiol. 1970 Dec;64(3):255–268. doi: 10.1099/00221287-64-3-255. [DOI] [PubMed] [Google Scholar]
  28. Weissbluth M., Shulman S. T., Holson B., Lerner C. Salmonella cholera-suis: a distinctive bacterial pathogen. J Pediatr. 1981 Mar;98(3):423–426. doi: 10.1016/s0022-3476(81)80710-x. [DOI] [PubMed] [Google Scholar]
  29. Wray C., Sojka W. J., Morris J. A., Brinley Morgan W. J. The immunization of mice and calves with gal E mutants of Salmonella typhimurium. J Hyg (Lond) 1977 Aug;79(1):17–24. doi: 10.1017/s0022172400052803. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES